People: SIGA Technologies Inc (SIGA.OQ)
SIGA.OQ on NASDAQ Stock Exchange Global Market
3.25USD
1 Aug 2013
3.25USD
1 Aug 2013
Price Change (% chg)
$0.06 (+1.88%)
$0.06 (+1.88%)
Prev Close
$3.19
$3.19
Open
$3.22
$3.22
Day's High
$3.27
$3.27
Day's Low
$3.16
$3.16
Volume
56,375
56,375
Avg. Vol
64,214
64,214
52-wk High
$4.59
$4.59
52-wk Low
$2.34
$2.34
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Eric Rose |
2007 | Chairman of the Board, Chief Executive Officer | |
Daniel Luckshire |
42 | 2011 | Chief Financial Officer, Executive Vice President, Secretary |
William Haynes |
55 | 2012 | Executive Vice President, General Counsel |
Dennis Hruby |
61 | 2000 | Chief Scientific Officer, Vice President |
James Antal |
62 | 2004 | Independent Director |
Michael Bayer |
65 | 2008 | Independent Director |
William Bevins |
2011 | Independent Director | |
Thomas Constance |
76 | 2001 | Independent Director |
Jeffrey Kindler |
57 | 2013 | Independent Director |
Joseph Marshall |
60 | 2009 | Independent Director |
Paul Savas |
2004 | Independent Director | |
Bruce Slovin |
77 | 2008 | Independent Director |
Andrew Stern |
62 | 2010 | Independent Director |
Frances Townsend |
2011 | Independent Director | |
Michael Weiner |
66 | 2001 | Independent Director |
Biographies
| Name | Description |
|---|---|
Eric Rose |
Dr. Eric A. Rose is Chairman of the Board, Chief Executive Officer of SIGA Technologies, Inc. He was elected Chairman of the Board of Directors on January 25, 2007, and, on March 1, 2007, became the Company’s Chief Executive Officer. Dr. Rose has served as a director of SIGA since April 19, 2001 and served as Interim Chief Executive Officer of SIGA during April-June 2001. Dr. Rose chaired the Department of Health Evidence & Policy at the Mount Sinai School of Medicine from 2008 to 2012, which he now serves as co-chair and professor. From 1994 through 2007, Dr. Rose served as Chairman of the Department of Surgery and Surgeon-in-Chief of the Columbia Presbyterian Center of New York Presbyterian Hospital. Dr. Rose is a former director of Abiomed, Inc., PharmaCore, Inc., TransTech Pharma, Inc., Nephros, Inc., Keryx Biopharmaceuticals, Inc. and Nexell Therapeutics Inc. Dr. Rose is a graduate of both Columbia College and Columbia University College of Physicians & Surgeons. In addition to his roles at SIGA, Dr. Rose holds a position as Executive Vice President – Life Sciences at MacAndrews & Forbes Holdings Inc. (“MacAndrews Holdings”), an affiliate of a SIGA shareholder. |
Daniel Luckshire |
Mr. Daniel J. Luckshire is Chief Financial Officer, Executive Vice President, Secretary of SIGA Technologies Inc. Prior to joining SIGA, Mr. Luckshire was a strategic advisor and private investor for a broad range of companies who are leaders within specialized market segments. Between 1998 and 2008, Mr. Luckshire was an investment banker at Merrill Lynch & Co., where he held positions of responsibility. Prior to his employment with Merrill Lynch, Mr. Luckshire was a member of the management team that built USI Insurance Services into a national insurance brokerage and was a CPA at Price Waterhouse LLP. Mr. Luckshire has a Master of Business Administration degree in Finance and Strategic Management from The Wharton School of the University of Pennsylvania and a Bachelor of Science degree in Accountancy from Villanova University. |
William Haynes |
Mr. William J. Haynes is an Executive Vice President, General Counsel of SIGA Technologies, Inc., since June 4, 2012. He has held a number of senior positions in the business world and the U.S. Government, including Chief Corporate Counsel at Chevron Corporation (2008 to 2012), General Counsel of the Department of Defense (2001 to 2008), partner in the national law firm Jenner & Block (1993 to 1996; 1999 to 2001), Vice President and Associate General Counsel of General Dynamics Corporation (1996 to 1999), and General Counsel of the Department of the Army (1989 to 1993). Mr. Haynes earned his Juris Doctor degree from Harvard Law School, and his Bachelor of Arts degree from Davidson College. |
Dennis Hruby |
Dr. Dennis E. Hruby is Chief Scientific Officer, Vice President of SIGA Technologies, Inc., since June 2000. From April 1, 1997 through June 2000, Dr. Hruby was Vice President of Research. From January 1996 through March 1997, Dr. Hruby served as a senior scientific advisor to SIGA. Dr. Hruby is a Professor of Microbiology at Oregon State University, and from 1990 to 1993 was Director of the Molecular and Cellular Biology Program and Associate Director of the Center for Gene Research and Biotechnology. Dr. Hruby specializes in virology and cell biology research, and the use of viral and bacterial vectors to produce recombinant vaccines. He is a member of the American Society of Virology, the American Society for Microbiology and a fellow of the American Academy of Microbiology. Dr. Hruby received a Ph.D. in microbiology from the University of Colorado Medical Center and a B.S. in microbiology from Oregon State University. |
James Antal |
Mr. James J. Antal is an Independent Director of SIGA Technologies, Inc., since November 2004. Mr. Antal has been an active consultant and founding investor in several Southern California based emerging companies since his retirement from Experian in 2002. He has served as Chief Financial Advisor to Black Mountain Gold Coffee Co. (2003 to 2005), and as Chief Financial Officer of Pathway Data, Inc. (2005 to 2009). Mr. Antal joined the board of directors and has served as the chairman of the audit committee for Cleveland Bio Labs since its initial public offering in July 2006. Mr. Antal was the Chief Financial Officer and Chief Investment Officer from 1996 to 2002 for Experian, a $1.6 billion global information services subsidiary of UK-based GUS plc. Prior to the GUS acquisition of Experian (the former TRW Inc. Information Systems and Services businesses), Mr. Antal held finance positions with TRW from 1978 to 1996, including Senior Vice President of Finance for TRW Information Systems and Services and TRW Inc. and Corporate Director of Financial Reporting and Accounting. He earned his undergraduate degree in accounting from The Ohio State University in 1973, and became a certified public accountant (Ohio) in 1974. He engaged in active practice as a CPA with Ernst & Ernst until 1978. Mr. Antal has served as a director of First American Real Estate Solutions, an Experian joint venture with First American Financial Corp. |
Michael Bayer |
Mr. Michael J. Bayer is an Independent Director of SIGA Technologies, Inc., since October 2008. Mr. Bayer has been a private consultant in the energy and national security sectors since 1992. Mr. Bayer is the President and Chief Executive Officer of Dumbarton Strategies LLC, an energy and national security consulting firm. He is the former Chairman of the U.S. Department of Defense’s Business Board and serves as a member of the Sandia National Laboratory’s National Security Advisory Panel, the U.S. Department of Defense’s Science Board and the Chief of Naval Operations’ Executive Panel. Mr. Bayer is a former director of Willbros Group, Inc., Dyncorp International, Stratos Global Corporation, Duratek, Inc. and Athena Inc. |
William Bevins |
Mr. William C. Bevins is an Independent Director of SIGA Technologies Inc., since March 2011. Mr. Bevins was President and Chief Executive Officer of Panavision Inc. from June 2009 to June 2011 and has been Senior Executive Vice President of MacAndrews Holdings since December 2010. Mr. Bevins was a consultant to MacAndrews Holdings from 1997 to 2000. He served as President and Chief Executive Officer, as well as a director, of Andrews Group Incorporated, an entertainment media holding company, from 1988 until his retirement in 1997, and of its two publicly traded operating subsidiaries, New World Communications Group Incorporated (from 1993 to 1997) and Marvel Entertainment Group, Inc. (from 1989 to 1996). From 1979 to 1988, he was Chief Financial Officer of Turner Broadcasting System, Inc., a media and entertainment company. |
Thomas Constance |
Mr. Thomas E. Constance is an Independent Director of SIGA Technologies, Inc., since April 2001. Mr. Constance is Chairman and, since 1994, a partner of Kramer Levin Naftalis & Frankel LLP, a law firm in New York City, which SIGA has retained to provide certain legal services. Mr. Constance serves as a director of Bond Street Holdings, Inc. and as a Trustee of the M.D. Sass Foundation and St. Vincent’s Services. He also serves on the Advisory Board of Directors of Barington Capital, L.P. |
Jeffrey Kindler |
Mr. Jeffrey B. Kindler is an Independent Director of SIGA Technologies, Inc., since March 21, 2013. Mr. Kindler is a Venture Partner at Lux Capital, a venture capital firm; a principal and senior advisor to Paragon Pharmaceuticals LLC, a global investment firm that builds and manages innovative pharmaceutical companies; and a director at Starboard Capital Partners, a Connecticut-based private equity firm. He also serves on the boards of Chipotle Mexican Grill Inc.; AgaMatrix Inc., a developer and manufacturer of diabetes products; Intrexon Corporation, a synthetic biology company; Sheridan Healthcare, Inc., a provider of healthcare solutions to physicians, hospitals, and outpatient centers; PPD, a global contract drug discovery and development research organization; Tufts University; the National Center on Addiction and Substance Abuse at Columbia University; and the Manhattan Theatre Club. Mr. Kindler was formerly the Chairman and Chief Executive Officer of Pfizer, Inc. which he joined in January 2002 and from which he retired in December 2010. He joined Pfizer as Executive Vice President and General Counsel and, prior to his appointment as CEO in July 2006, he served as a Vice Chairman of the Company. In 1996, Mr. Kindler joined McDonald's Corporation as Executive Vice President and General Counsel and in 1990 Mr. Kindler joined the General Electric Company as Vice President of Litigation and Legal Policy. |
Joseph Marshall |
Mr. Joseph W. Marshall is an Independent Director of SIGA Technologies,Inc., since 2009. Mr. Marshall is the former President and Chief Executive Officer of Temple University Health System (2001-2008). In 2000, he became Chair of Temple University Health System and served in that capacity until 2007. Prior to 2000, Marshall was a founding partner at Goldman & Marshall P.C., Philadelphia, PA, a corporate healthcare law firm. He received his B.A. and J.D. degrees (1975 and 1979, respectively) from Temple University. In 1990, he joined the Temple University Board of Trustees. He was a founding member of the Temple University Health System Board of Directors in 1995. He served on the Pennsylvania State Ethics Commission in the 1980s and early 1990s, including as Chairman for a portion of that period. During 2005-2006, he served as a Member of the Federal Medicaid Commission. Additionally, during 2004-2006, he served as a Member of the Pennsylvania Gaming Control Board. |
Paul Savas |
Mr. Paul G. Savas is an Independent Director of SIGA Technologies, Inc., since January 2004. Mr. Savas is Executive Vice President and Chief Financial Officer at MacAndrews Holdings. He joined MacAndrews Holdings in 1994 as Director of Corporate Finance, served in various positions of increasing responsibility and became Chief Financial Officer in 2007. He serves as Executive Vice President and Chief Financial Officer of M & F Worldwide Corp. and serves as a director of Harland Clarke Holding Corp. and TransTech Pharma, Inc. During the past six years, Mr. Savas served as a member of the board of managers of REV Holdings LLC. |
Bruce Slovin |
Mr. Bruce Slovin is an Independent Director of SIGA Technologies, Inc., since October 2008. Mr. Slovin has been the President of 1 Eleven Associates, LLC, a private investment firm, for five years. From 1980 to 2000, Mr. Slovin was an executive officer of MacAndrews Holdings and several of its affiliates. Mr. Slovin is a director of Cantel Industries and a former director of M & F Worldwide Corp. |
Andrew Stern |
Mr. Andrew L. Stern is an Independent Director of SIGA Technologies, Inc., since June 2010. Mr. Stern was formerly the president of Service Employees International Union (SEIU), the second union in the United States and Canada and was elected to that role in 1996. Mr. Stern currently holds an appointment as the Alice B. Grant Labor Leader in Residence at the Cornell University School of Industrial and Labor Relations. He is a board member of the Broad Foundation, the Open Society Institute, the Economic Policy Institute, a lifetime Trustee of the Aspen Institute, the President of the Kaiser Permanente Partnership and SEIU’s National Industry Pension. |
Frances Townsend |
Ms. Frances Fragos Townsend is an Independent Director of SIGA Technologies Inc., since March 2011. Ms. Townsend is Executive Vice President of Worldwide Government, Legal and Business Affairs at MacAndrews Holdings. She joined MacAndrews Holdings in October 2010 as Senior Vice President of Worldwide Government, Legal and Business Affairs. Ms Townsend previously served as Homeland Security Advisor to President George W. Bush from May 2005 until January 2008. She served as Deputy Assistant to the President and Deputy National Security Advisor for Combating Terrorism from May 2003 to May 2004. Prior to serving the President, Ms. Townsend was the first Assistant Commandant for Intelligence for the U.S. Coast Guard. Before that, Ms. Townsend spent 13 years at the U.S. Department of Justice under the administration of President George H.W. Bush, President Bill Clinton and President George W. Bush. |
Michael Weiner |
Dr. Michael A. Weiner is an Independent Director of SIGA Technologies, Inc., since 2001. Dr. Weiner has been the Hettinger Professor of Pediatrics at Columbia University College of Physicians and Surgeons since 1996. Dr. Weiner is the Director of Pediatric Oncology at New York Presbyterian Hospital. Dr. Weiner was a director of Nexell Therapeutics, Inc. (f/k/a VimRx) from March 1996 to February 1999. Dr. Weiner is a 1972 graduate of the New York State Health Sciences Center at Syracuse and was a post-graduate student at New York University and Johns Hopkins University. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Eric Rose |
1,846,140 |
Daniel Luckshire |
901,277 |
William Haynes |
643,008 |
Dennis Hruby |
1,409,910 |
James Antal |
-- |
Michael Bayer |
-- |
William Bevins |
-- |
Thomas Constance |
-- |
Jeffrey Kindler |
-- |
Joseph Marshall |
-- |
Paul Savas |
-- |
Bruce Slovin |
-- |
Andrew Stern |
-- |
Frances Townsend |
-- |
Michael Weiner |
-- |
As Of 30 Dec 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
Eric Rose |
1,840,000 | 1,284,933 |
Daniel Luckshire |
0 | 0 |
William Haynes |
0 | 0 |
Dennis Hruby |
1,175,000 | 3,969,917 |
James Antal |
0 | 0 |
Michael Bayer |
0 | 0 |
William Bevins |
0 | 0 |
Thomas Constance |
0 | 0 |
Jeffrey Kindler |
0 | 0 |
Joseph Marshall |
0 | 0 |
Paul Savas |
0 | 0 |
Bruce Slovin |
0 | 0 |
Andrew Stern |
0 | 0 |
Frances Townsend |
0 | 0 |
Michael Weiner |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
SLOVIN BRUCE |
15,000 | $3.83 |
MARSHALL JOSEPH W III |
7,000 | $3.59 |
TOWNSEND FRANCES FRAGOS |
15,000 | $0.00 |
CONSTANCE THOMAS E |
15,000 | $0.00 |
WEINER MICHAEL A |
15,000 | $0.00 |
SAVAS PAUL G |
15,000 | $0.00 |
BEVINS WILLIAM C |
15,000 | $0.00 |
STERN ANDREW L |
15,000 | $0.00 |
SLOVIN BRUCE |
15,000 | $0.00 |
MARSHALL JOSEPH W III |
15,000 | $0.00 |
BAYER MICHAEL J |
15,000 | $0.00 |
ANTAL JAMES J |
15,000 | $0.00 |
LUCKSHIRE DANIEL J |
4,830 | $4.28 |
HRUBY DENNIS E |
9,253 | $4.28 |
LUCKSHIRE DANIEL J |
11,666 | $0.00 |
ROSE ERIC A |
66,666 | $0.00 |
HRUBY DENNIS E |
25,000 | $0.00 |
ROSE ERIC A |
27,314 | $4.28 |
BEVINS WILLIAM C |
50,000 | $2.44 |
ROSE ERIC A |
123,666 | $2.10 |
MARSHALL JOSEPH W III |
5,000 | $3.02 |
SAVAS PAUL G |
10,000 | $2.83 |
SLOVIN BRUCE |
50,000 | $2.80 |
SAVAS PAUL G |
5,000 | $2.80 |
STERN ANDREW L |
1,000 | $4.99 |

